COVID-19 gender policy changes support female scientists and improve research quality.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
09 02 2021
Historique:
entrez: 3 2 2021
pubmed: 4 2 2021
medline: 13 2 2021
Statut: ppublish

Résumé

With more time being spent on caregiving responsibilities during the COVID-19 pandemic, female scientists' productivity dropped. When female scientists conduct research, identity factors are better incorporated in research content. In order to mitigate damage to the research enterprise, funding agencies can play a role by putting in place gender equity policies that support all applicants and ensure research quality. A national health research funder implemented gender policy changes that included extending deadlines and factoring sex and gender into COVID-19 grant requirements. Following these changes, the funder received more applications from female scientists, awarded a greater proportion of grants to female compared to male scientists, and received and funded more grant applications that considered sex and gender in the content of COVID-19 research. Further work is urgently required to address inequities associated with identity characteristics beyond gender.

Identifiants

pubmed: 33531366
pii: 2023476118
doi: 10.1073/pnas.2023476118
pmc: PMC8017703
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

Competing interest statement: H.O.W. holds a funded grant as principal investigator from the second competition described in the paper. J.H. is employed by the Canadian Institutes of Health Research Institute of Gender and Health. C.T. is a Scientific Institute director at Canadian Institutes of Health Research and is therefore partially employed by the Canadian Institutes of Health Research.

Références

Nature. 2020 Jul;583(7816):479-481
pubmed: 32647354
Sci Adv. 2019 Oct 09;5(10):eaaw7238
pubmed: 31633016
Lancet. 2019 Feb 9;393(10171):550-559
pubmed: 30739690
Lancet. 2020 May 30;395(10238):1673-1676
pubmed: 32401716
Am J Public Health. 2020 Oct;110(10):1523-1527
pubmed: 32816541
BMJ Glob Health. 2020 Jul;5(7):
pubmed: 32527733
Nature. 2019 Nov;575(7781):137-146
pubmed: 31695204
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864
Elife. 2020 Jun 15;9:
pubmed: 32538780
Nat Hum Behav. 2018 Oct;2(10):726-734
pubmed: 31406295

Auteurs

Holly O Witteman (HO)

Faculty of Medicine, Université Laval, Quebec City, QC G1V 0A6, Canada.

Jenna Haverfield (J)

Institute of Gender and Health, Canadian Institutes of Health Research, Ottawa, ON, K1A 0W9, Canada.

Cara Tannenbaum (C)

Institute of Gender and Health, Canadian Institutes of Health Research, Ottawa, ON, K1A 0W9, Canada; cara.tannenbaum@umontreal.ca.
Faculty of Medicine, Université de Montréal, Montreal, QC H3C 3J7, Canada.
Faculty of Pharmacy, Université de Montréal, Montreal, QC H3C 3J7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH